Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: A quantitative study of open lung biopsies

European Respiratory Journal

Volumn 14, Issue 2, 1999, Pages 251-257

  Majumdar, S ^b   Li, D ^b   Ansari, T ^b   Pantelidis, P ^b   Black, C M ^b   Gizycki, M ^b   Du Bois, R M ^b   Jeffery, P K ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Alveolitis; Cytokines; Fibrosis; Lung; Scleroderma

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBROSING ALVEOLITIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; LUNG BIOPSY; LUNG DISEASE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

ADULT; AGED; BIOPSY; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MALE; MIDDLE AGED; PULMONARY FIBROSIS; REFERENCE VALUES; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032824790     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14b03.x     Document Type: Article

References (39)

1. Wells AU, Cullinan P, Hansell DM, et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994; 149: 1583-1590.
2. Wells AU, Lorimer S, Majumdar S, et al. Fibrosing alveolitis in systemic sclerosis: increase in memory T cells in lung interstitium. Eur Respir J 1995; 8: 266-271.
3. Campbell DA, Poulter LW, Janossy G, du Bois RM. Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax 1985; 40: 405-411.
4. Southcott AM, Jones KP, Li D, et al. Interleukin-8 differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 1995; 151: 1604-1612.
5. Wells AU, Hansell DM, Cailes J, et al. Bronchoalveolar lavage (BAL) cellularity in fibrosing alveolitis: a comparison between lone cryptogenic fibrosing alveolitis (CFA) and the fibrosing alveolitis of systemic sclerosis (FASSc). Eur Respir J 1995; 8: 453s (Abstract).
6. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-1413.
7. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87: 1541-1546.
8. Robinson DS, Durham SR, Kay AB. Cytokines: 3-Cytokines in asthma. Thorax 1993; 48: 845-853.
9. Moller DR, Forman JD, Liu MC, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 156: 4952-4960.
10. Wallace WAH, Ramage EA, Lamb D, Howie SEM. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 1995; 101: 436-441.
11. Furuie H, Yamasaki H, Suga M, Ando M. Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis. Eur Respir J 1997; 10: 787-794.
12. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 19808; 23: 581-590.
13. Hamid QA, Corrin B, Dewar A, Hoefler H, Sheppard MN. Expression of Gastrin-releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung. J Pathol 1990; 161: 145-151.
14. Mason DY, Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol 1978; 31: 454-460.
15. Malik NJ, Daymon ME. Improved double immunoenzyme labelling using alkaline phosphatase and horseradish peroxidase. J Clin Pathol 1982; 35: 1092-1094.
16. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976; 85: 769-788.
17. Wright PH, Heard BE, Steel SJ, Turner-Warwick M. Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic and physiological features. Br J Dis Chest 1981; 75: 61-70.
18. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144: 706-713.
19. Wells AU, Lorimer S, Jeffery PK, et al. Fibrosing alveolitis associated with systemic sclerosis is characterised by the presence of antigen-primed T cells in the lung interstitium. Am Rev Respir Dis 1992; 145: A466 (Abstract).
20. Wallace WAH, Roberts SN, Caldwell H, et al. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax 1994; 49: 218-224.
21. Wallace WAH, Schofield JA, Lamb D, Howie SEM. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 1994; 49: 1139-1145.
22. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, Woodcock AA. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995; 50: 1234-1239.
23. Wangoo A, Shaw RJ, Diss TC, Farrell PJ, du Bois RM, Nicholson AJ. Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus. Thorax 1997; 52: 888-891.
24. Haslam PL, Turton CWG, Heard B, et al. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax 1980; 35: 9-18.
25. du Bois RM. Cryptogenic fibrosing alveolitis and cryptogenic organising pneumonia. In: Brewis RAL, Corrin B, Gibson GJ, Geddes DM, eds. Textbook of Respiratory Medicine. 2nd edn. Bailliere Tindall, London 1995; p. 1376.
26. Gauldie J, Jordana M, Cox G. Cytokines and Pulmonary Fibrosis. Thorax 1993; 48: 931-935.
27. Buttner C, Skupin A, Reimann T, et al. Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol 1997; 17: 315-325.
28. Feghali CA, Bost KL, Boulware DW, Levy LS. Human recombinant interleukin 4 induces proliferation and interleukin 6 production by cultured human skin fibroblasts. Clin Immunol Immunopath 1992; 63: 182-187.
29. Postlethwaite AK, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1997; 90: 1479-1485.
30. Sempowski GD, Beckmann MP, Derdak S, Phipps RP. Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 1994; 152: 3606-3614.
31. Gharaee-Kermani M, Phan SH. Lung interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 1997; 16: 438-447.
32. Rosenbloom J, Feldman G, Freundlich B, et al. Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon. Biochem Biophys Res Commun 1984; 123: 365-372.
33. Stephenson ML, Krane SM, Amento EP, et al. Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of the procollagen mRNAs. FEBS Lett 1985; 180: 43-50.
34. Czaja MJ, Weiner FR, Eghbali M, et al. Differential effects of gamma-interferon on collagen and fibronectin gene expression. J Biol Chem 1987; 262: 13348-13351.
35. Elias JA, Jimenez SA, Freundlich B. Recombinant gamma, alpha and beta interferon regulation of human lung fibroblast proliferation. Am Rev Respir Dis 1987; 135: 62-65.
36. Elias JA. Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms. Am Rev Respir Dis 1988; 138: 652-658.
37. Duncan MR, Berman B. Gamma-interferon is the lymphokine and beta-interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985; 162: 516-527.
38. Prior C, Haslam PL. In vivo levels and in vitor production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol 1992; 88: 280-287.
39. DHein R, Behr J, Hungden M, et al. Treatment of systemic sclerosis with gamma-interferon. Br J Dermatol 1992; 126: 496-501.